These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16087142)

  • 21. A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group.
    Køber L; Torp-Pedersen C; Carlsen JE; Bagger H; Eliasen P; Lyngborg K; Videbaek J; Cole DS; Auclert L; Pauly NC
    N Engl J Med; 1995 Dec; 333(25):1670-6. PubMed ID: 7477219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-chain omega-3 fatty acids from fish reduce sudden cardiac death in patients with coronary heart disease.
    Richter WO
    Eur J Med Res; 2003 Aug; 8(8):332-6. PubMed ID: 12915328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The treatment of arrhythmias in post-infarction patients: the role of n-3 fatty acids. Cons].
    Lunati M
    Ital Heart J; 2003 Dec; 4 Suppl 8():55S-58S. PubMed ID: 15005533
    [No Abstract]   [Full Text] [Related]  

  • 25. N-3 fatty acids and cardiac function after myocardial infarction in Denmark.
    Skou HA; Toft E; Christensen JH; Hansen JB; Dyerberg J; Schmidt EB
    Int J Circumpolar Health; 2001 Aug; 60(3):360-5. PubMed ID: 11590875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The treatment of arrhythmias in post-infarction patients: the role of n-3 fatty acids. Pros].
    Schweiger C
    Ital Heart J; 2003 Dec; 4 Suppl 8():47S-54S. PubMed ID: 15005532
    [No Abstract]   [Full Text] [Related]  

  • 27. Beta-blocker in post-myocardial infarct survivors with preserved left ventricular systolic function.
    Siu CW; Pong V; Jim MH; Yue WS; Ho HH; Li SW; Lau CP; Tse HF
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):675-80. PubMed ID: 20132502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction.
    Orn S; Cleland JG; Romo M; Kjekshus J; Dickstein K
    Am J Med; 2005 Jul; 118(7):752-8. PubMed ID: 15989909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of dietary n-3 polyunsaturated fatty acids on myocardial resistance to ischemia-reperfusion injury in rats.
    Zeghichi-Hamri S; de Lorgeril M; Salen P; Chibane M; de Leiris J; Boucher F; Laporte F
    Nutr Res; 2010 Dec; 30(12):849-57. PubMed ID: 21147368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Highly concentrated omega-3-fatty acids. A new means in the secondary prevention].
    MMW Fortschr Med; 2005 Oct; 147(43):60-1. PubMed ID: 16302426
    [No Abstract]   [Full Text] [Related]  

  • 32. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction.
    Solomon SD; Skali H; Anavekar NS; Bourgoun M; Barvik S; Ghali JK; Warnica JW; Khrakovskaya M; Arnold JM; Schwartz Y; Velazquez EJ; Califf RM; McMurray JV; Pfeffer MA
    Circulation; 2005 Jun; 111(25):3411-9. PubMed ID: 15967846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ambulatory ECG-based T-wave alternans predicts sudden cardiac death in high-risk post-MI patients with left ventricular dysfunction in the EPHESUS study.
    Stein PK; Sanghavi D; Domitrovich PP; Mackey RA; Deedwania P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1037-42. PubMed ID: 18554193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The predictive value for major arrhythmic events of ventricular arrhythmias, particularly nonsustained ventricular tachycardias, in the subacute phase of a fibrinolyzed infarct. An analysis of GISSI-2 data. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Giani P; Avanzini F; Bagliani G; Galati A; Pucci P; Santoro E
    G Ital Cardiol; 1995 Jan; 25(1):77-87. PubMed ID: 7642014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardioprotective and anti-arrhythmia omega 3 fatty acids. Protection from sudden cardiac death].
    MMW Fortschr Med; 2002 Sep; 144(37):54. PubMed ID: 12380341
    [No Abstract]   [Full Text] [Related]  

  • 38. Empiric long-term amiodarone prophylaxis following myocardial infarction. A meta-analysis.
    Zarembski DG; Nolan PE; Slack MK; Caruso AC
    Arch Intern Med; 1993 Dec; 153(23):2661-7. PubMed ID: 7504440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic effects of omega-3 fatty acids: from epidemiology to bedside.
    De Caterina R; Madonna R; Zucchi R; La Rovere MT
    Am Heart J; 2003 Sep; 146(3):420-30. PubMed ID: 12947358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Highly purified omega-3 polyunsaturated fatty acids in clinical development.
    Vik H
    Herz; 2006 Dec; 31 Suppl 3():83-95. PubMed ID: 17575810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.